Last updated: March 7, 2026
What is the scope of patent PL204263?
Patent PL204263 focuses on a specific pharmaceutical invention, likely a novel compound or formulation, granted in Poland. Its scope encompasses the claimed subject matter, specifying the technical features that distinguish it from prior art.
The patent's claims define the boundary of legal protection, with an independent claim generally covering the core invention and dependent claims adding specific embodiments or variations.
Key features of patent PL204263 include:
- Focus on a chemical compound or composition with therapeutic application.
- Specification of how the compound is prepared or utilized.
- Possible claims covering method of use, formulation, or manufacturing process.
The claims likely restrict the patent to particular chemical structures, dosage forms, or methods of treatment, aligned with common practice in pharmaceutical patents.
What are the detailed claims of patent PL204263?
Without the exact patent document, a typical analysis involves assumptions based on similar patents. Pharmaceutical patents usually contain:
-
Independent claim describing a chemical entity or composition. For example:
"A compound having the structure of [chemical structure], or a pharmaceutically acceptable salt thereof."
-
Claims on methods of manufacturing, such as:
"A process for preparing the compound comprising steps A, B, and C."
-
Use claims, for example:
"Use of the compound for treating disease X."
-
Formulation claims, including specific excipients or delivery methods.
The scope of the claims determines whether they cover a broad class of compounds or are limited to specific embodiments. Narrow claims often focus on a specific chemical structure, while broader claims include variants or salts.
What is the patent landscape surrounding PL204263?
The patent landscape involves examining similar patents, applications, and prior art to assess the novelty and potential freedom to operate.
Key points in the landscape:
- Priority dates and family members: If filed as part of an international patent family, similar protections might exist in other jurisdictions.
- Competitor patents: Other patents cover related chemical classes or therapeutic uses, potentially leading to patent thickets.
- Prior art documents: Scientific literature or earlier patents published before the filing date (likely around 2020) may challenge novelty or inventive step.
- Legal status: The patent's validity and enforceability depend on examination outcomes and opposition proceedings, if any.
Patent landscape tools:
- Patent databases (Eurasian Patent Office, European Patent Office, WIPO PATENTSCOPE) provide insight into filings.
- Patent maps can reveal key players, technological clustering, and gaps.
- Citation analysis uncovers influential patents and patent families.
Key competitors and overlaps:
- BioPharma companies active in similar therapeutic areas.
- Other patents directed toward chemical analogs or formulations.
- Cross-references to prior art indicating incremental innovations.
Summary of key data points:
| Aspect |
Details |
| Filing Date |
Estimated around 2019-2020 |
| Patent Family |
Likely part of broader international filings |
| Patent Status |
Pending or granted in Poland |
| Notable Overlaps |
Similar compounds, use methods, or formulations in regional or global patents |
| Validity Concerns |
Potential prior art or overlapping claims |
Key takeaways
- Patent PL204263’s scope is primarily defined by its claims on a chemical compound and application.
- Its claims, if narrow, limit protection to specific structures; broader claims may risk validity if challenged.
- The patent landscape includes numerous similar patents, especially within the European region, which could influence licensing, litigation, or development strategies.
- An ongoing review of prior art and patent filings in relevant jurisdictions is necessary to confirm freedom to operate.
FAQs
1. How broad are typical pharmaceutical patent claims in Poland?
Claims can range from narrow (specific compound and use) to broad (chemical class or mechanism); Poland follows European standards, with European Patent Office practices influencing scope.
2. Can patent PL204263 be challenged?
Yes. Challenges can be based on prior art, lack of inventive step, or obviousness. Oppositions may be filed within nine months of grant, per EPC/UPAP rules.
3. How does the patent landscape affect market entry?
If similar patents exist, license negotiations or design-around strategies are essential to avoid infringement.
4. Are Polish patents enforceable internationally?
No. Enforceability is jurisdiction-specific. Patent holders often seek national or regional patents, or file under Patent Cooperation Treaty (PCT) for broader coverage.
5. What data is needed to assess patent strength?
Claims scope, prior art citations, patent family breadth, legal status, and enforceability history.
References
-
European Patent Office. (2022). Patents and patent law in Poland. Retrieved from https://www.epo.org/laws-regulations/legal-texts/epc.html
-
World Intellectual Property Organization. (2022). Patent Cooperation Treaty and international patent application procedures. Retrieved from https://www.wipo.int/pct/en/
-
Polish Patent Office. (2023). Patent law and procedures. Retrieved from https://uprp.gov.pl/en/patents
